TIG Advisors »

Xenon Pharmaceuticals shares owned by TIG Advisors

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by TIG Advisors from 13F filings

Historical chart of TIG Advisors investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by TIG Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by TIG Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 64k 46.06

More positions owned by TIG Advisors

United States Steel Corporation Put Option (X)
Capri Holdings SHS (CPRI)
stock
ImmunoGen
Ansys Call Option (ANSS)
Endeavor Group Hldgs Cl A Com Put Option (EDR)
Pioneer Natural Resources (PXD)
Albertsons Cos Common Stock Put Option (ACI)
Cleveland-cliffs (CLF)
Chevron Corporation (CVX)
Cytokinetics Com New Call Option (CYTK)
Argenx Se Sponsored Adr Call Option (ARGX)
Apellis Pharmaceuticals (APLS)
Gracell Biotechnologies Sponsored Ads
Neurocrine Biosciences Call Option (NBIX)

View all positions for TIG Advisors

Top funds holding Xenon Pharmaceuticals

venBio Select Advisor
Wellington Management Company
Commodore Capital
Paradigm Biocapital Advisors
Braidwell
First Light Asset Management
Alliancebernstein
Marshall Wace
Citadel Advisors
Perceptive Advisors
Baker Bros. Advisors
Henderson Group
BVF
Point72 Asset Management
Avidity Partners Management

View all funds holding Xenon Pharmaceuticals